Option 3 seems to have the higher probability of c
Post# of 30028
Quote:
The possibility is further fueled by Gerald's hint that more diagnostic assets will be added to AMBSDX (contributed from the JV partner as part of JV deal?).
Quote:
In addition, we will add our NuroPro technology for Parkinson’s and other diagnostic assets to the Amarantus Diagnostics portfolio as well
Good catch on this one. Was thinking Gerald was talking about adding BC-SeraPro, but he did say "assets". Maybe CTE Diagnostic is coming to fruition.